Benedikt Schrage

Publications
CV
Public outreach and news

Articles

Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(7):1212-1222

Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.

Schrage B; Lund LH; Benson L; Dahlström U; Shadman R; Linde C; Braunschweig F; Levy WC; Savarese G
Article: ESC HEART FAILURE. 2022;9(2):822-833

Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure.

Lindberg F; Lund LH; Benson L; Schrage B; Edner M; Dahlström U; Linde C; Rosano G; Savarese G
Article: EUROPACE. 2022;24(1):48-57

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.

Schrage B; Lund LH; Melin M; Benson L; Uijl A; Dahlström U; Braunschweig F; Linde C; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2021;23(11):1844-1854

Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.

Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
Article: JOURNAL OF CARDIAC FAILURE. 2021;27(8):888-895

Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.

Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2021;23(6):1012-1022

Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry.

Becher PM; Schrage B; Ferrannini G; Benson L; Butler J; Carrero JJ; Cosentino F; Dahlström U; Mellbin L; Rosano GMC; Sinagra G; Stolfo D; Lund LH; Savarese G
Article: JOURNAL OF INTERNAL MEDICINE. 2021;289(3):369-384

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry.

Savarese G; Hage C; Benson L; Schrage B; Thorvaldsen T; Lundberg A; Fudim M; Linde C; Dahlström U; Rosano GMC; Lund LH
Article: HEART. 2021;107(3):229-236

Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure.

Schrage B; Lund LH; Benson L; Stolfo D; Ohlsson A; Westerling R; Westermann D; Strömberg A; Dahlström U; Braunschweig F; Ferreira JP; Savarese G
Article: JOURNAL OF CARDIAC FAILURE. 2020;26(12):1034-1042

Heart Failure in Patients Undergoing Elective and Emergency Noncardiac Surgery: Still a Poorly Addressed Risk Factor.

Faxén UL; Hallqvist L; Benson L; Schrage B; Lund LH; Bell M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020;313:76-82

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.

Savarese G; Settergren C; Schrage B; Thorvaldsen T; Löfman I; Sartipy U; Mellbin L; Meyers A; Farsani SF; Brueckmann M; Brodovicz KG; Vedin O; Asselbergs FW; Dahlström U; Cosentino F; Lund LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2020;22(1):103-112

Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry.

Stolfo D; Uijl A; Benson L; Schrage B; Fudim M; Asselbergs FW; Koudstaal S; Sinagra G; Dahlström U; Rosano G; Savarese G
Article: CIRCULATION. 2019;140(19):1530-1539

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry.

Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G

All other publications

KI thesis / dissertation: 2022

Comprehensive assessment of device-based therapy for heart failure with reduced ejection fraction

Schrage, Benedikt Norbert
Review: ESC HEART FAILURE. 2020;7(6):3438-3451

Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials.

Savarese G; Schrage B; Cosentino F; Lund LH; Rosano GMC; Seferovic P; Butler J
Letter: CIRCULATION. 2020;141(11):e648-e649

Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry".

Schrage B; Linde C; Braunschweig F; Savarese G

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2022-2025
Affiliated to Research, Department of Medicine, Karolinska Institutet, 2022-2025
Affiliated to Research, Department of Medicine, Karolinska Institutet, 2022-2025

Articles

All other publications

Employments

News from KI

Events from KI